Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms
Laura F. Mendez Luque, Amanda Blackmon, Gajalakshmi Ramanathan, et al.
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 3, pp. 145-153
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Risk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients
Anna Ravn Landtblom, Therése Andersson, Paul W. Dickman, et al.
Leukemia (2020) Vol. 35, Iss. 2, pp. 476-484
Open Access | Times Cited: 47
Suppressed activation of the IRF7 and TLR9 by JAK2V617F gold nanoparticles
Berkay Tokcan, Esra Nur Demirtaş, Selçuk Sözer
Immunogenetics (2025) Vol. 77, Iss. 1
Open Access
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
Vincenzo Nasillo, Giovanni Riva, Ambra Paolini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1906-1906
Open Access | Times Cited: 28
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
Wenjuan Fan, Weijie Cao, Jianxiang Shi, et al.
Annals of Hematology (2023) Vol. 102, Iss. 7, pp. 1745-1759
Open Access | Times Cited: 12
High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms
Kathrine Gotfredsen, Andreas Abou-Taha, Charlotte Liisborg, et al.
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 2, pp. 41-41
Open Access
Intersecting Pathologies: Polycythemia Vera and Recurrent Infections in an Elderly Patient
P K Saha, Ertan Şahi̇n, Nirupam Nadella, et al.
Cureus (2025)
Open Access
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis
Martina Barone, Lucia Catani, Francesca Ricci, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Neutrophil Death in Myeloproliferative Neoplasms: Shedding More Light on Neutrophils as a Pathogenic Link to Chronic Inflammation
Dragana Marković, Irina Maslovarić, Dragoslava Djikić, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1490-1490
Open Access | Times Cited: 14
Putative Role of Neutrophil Extracellular Trap Formation in Chronic Myeloproliferative Neoplasms
Dragana Marković, Irina Maslovarić, Marijana Kovačić, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4497-4497
Open Access | Times Cited: 8
Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
Scott S. Auerbach, Beana Puka, Upendarrao Golla, et al.
Life (2024) Vol. 14, Iss. 3, pp. 309-309
Open Access | Times Cited: 2
Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia—A nationwide population‐based study
Nikolaj Mannering, Dennis Lund Hansen, Guillaume Moulis, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1464-1475
Open Access | Times Cited: 2
JAK2V617F‐dependent down regulation of SHP‐1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF‐β
Céline Aoun, Nabih Maslah, Saravanan Ganesan, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 20
Open Access | Times Cited: 2
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms
Vibe Skov, Mads Thomassen, Lasse Kjær, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270669-e0270669
Open Access | Times Cited: 12
Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different Oncogenes
Jan Stetka, Ján Gurský, Julie Liñan Velasquez, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 903-903
Open Access | Times Cited: 17
Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?
María Luz Morales, Francisca Ferrer‐Marín
Cancers (2023) Vol. 15, Iss. 4, pp. 1348-1348
Open Access | Times Cited: 5
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia‐chromosome negative myeloproliferative neoplasms
Vibe Skov, Mads Thomassen, Lasse Kjær, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 5, pp. 805-814
Open Access | Times Cited: 5
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
Hans Carl Hasselbalch, Peter Junker, Vibe Skov, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4323-4323
Open Access | Times Cited: 5
Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms
Nicolas Chatain, Steffen Koschmieder, Edgar Jost
Cancers (2020) Vol. 12, Iss. 8, pp. 2250-2250
Open Access | Times Cited: 14
Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma
Shanshan Sun, Yang Fu, Jianyang Lin
Oncology Letters (2020)
Open Access | Times Cited: 13
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases
Enrico La Spina, Sebastiano Giallongo, Cesarina Giallongo, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis
Sunčica Kapor, Sanja Momčilović, Slobodan Kapor, et al.
Advances in experimental medicine and biology (2023), pp. 273-290
Closed Access | Times Cited: 4
Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as new possible minor criteria for diagnosis of polycythemia vera
Min Jung Kim, Seong Soon Kwon, Young Sok Ji, et al.
International Journal of Laboratory Hematology (2023) Vol. 45, Iss. 6, pp. 853-859
Closed Access | Times Cited: 4
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms
Christina Schjellerup Eickhardt‐Dalbøge, Henrik Nielsen, Kurt Fuursted, et al.
European Journal Of Haematology (2024) Vol. 112, Iss. 5, pp. 776-787
Open Access | Times Cited: 1
SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms
Garima Pandey, Lucia Mazzacurati, Tegan M. Rowsell, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1040-1055
Open Access | Times Cited: 1
Systemic Inflammation Index: A New Candidate Minor Criterion in the Diagnosis of <em>Polycythemia vera</em>
Emine Gültürk, Korhan Kapucu
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top